Unifortune Investment Holdings Group

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 5, 2022	Atom Bioscience & Pharmaceutical	$45.0M Series C	Yuhang Teng, Huang Pu	Efung Capital, Hongshan Capital Group (Sequoia Capital China), Kaitai Capital, Livzon Pharmaceutical Group

Total Raised

N/A

Valuation

N/A